This site is intended for healthcare professionals only
LoginRegister
S pneumoniae infection treatment: DCGI nod to Biological E 14-valent paediatric Pneumococcal Conjugate VaccineS pneumoniae infection treatment: DCGI nod to Biological E 14-valent paediatric Pneumococcal...
COVID-19 vaccination more protective against death and hospitalization compared to natural immunityCOVID-19 vaccination more protective against death and hospitalization compared to natural immunity
Bharat Serums and Vaccines to buy Firstline Pharma, Genomicks to expand presence in womens health in MalaysiaBharat Serums and Vaccines to buy Firstline Pharma, Genomicks to expand presence in women's health...
Antiviral drug nirmatrelvir plus ritonavir effective in reducing COVID-19 hospitalization among vaccinated adults 50 and overAntiviral drug nirmatrelvir plus ritonavir effective in reducing COVID-19 hospitalization among...
SII Cervical cancer vaccine CERVAVAC likely to be launched in April next yearSII Cervical cancer vaccine CERVAVAC likely to be launched in April next year
Ebola vaccines safety and immunogenicity trial shows potentialEbola vaccines safety and immunogenicity trial shows potential
Pfizer eyes USD 10 billion- USD 15 billion in potential revenue from mRNA vaccines by 2030Pfizer eyes USD 10 billion- USD 15 billion in potential revenue from mRNA vaccines by 2030
Include intranasal COVID vaccine iNCOVACC in CoWIN portal: Bharat Biotech urges CentreInclude intranasal COVID vaccine iNCOVACC in CoWIN portal: Bharat Biotech urges Centre
Two doses of Jynneos vaccine significantly effective in treating monkeypoxTwo doses of Jynneos vaccine significantly effective in treating monkeypox
1.5 lakh Covid vaccine doses procured from Zydus Cadila: Govt1.5 lakh Covid vaccine doses procured from Zydus Cadila: Govt
Takeda Dengue Tetravalent Vaccine QDENGA gets European Commission nodTakeda Dengue Tetravalent Vaccine QDENGA gets European Commission nod
FDA authorizes availability of bivalent COVID-19 vaccines for children six months to 4 years of ageFDA authorizes availability of bivalent COVID-19 vaccines for children six months to 4 years of age
X